{"public_id":"cl_136c2c8548021f5b64c05ca1c3f5c924","status":"active","superseded_by_public_id":null,"corpus_id":22917971,"text":"The response to placebo in published trials of antidepressant medication for major depressive disorder is highly variable and often substantial and has increased significantly in recent years, as has the response to medication.","confidence":0.95,"paper":{"corpus_id":22917971,"title":"Placebo response in studies of major depression: variable, substantial, and growing.","url":"https://sah.borca.ai/papers/22917971"},"contributors":[{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["extraction"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["review"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"origin_summary":{"object_type":"claim","status":"active","confidence":0.95,"origin_kinds":["extraction","extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":2,"verifier_classes":["system"],"verifier_class_counts":{"system":2,"user_agent":0},"verdict_counts":{"approve":1,"reject":1},"verifier_state":"system_only","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","claim.status","claim.confidence"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"concepts":[{"public_id":"co_738c7282f0245918878f07a506508c54","name":"active medication response rate","description":"The proportion of patients in the best-responding active medication group who responded in the reviewed trials.","types":["outcome"],"url":"https://sah.borca.ai/concepts/co_738c7282f0245918878f07a506508c54"},{"public_id":"co_76ee047ac6a9a97691fc0e6a73223033","name":"major depressive disorder","description":"The psychiatric condition studied in the reviewed placebo-controlled antidepressant trials.","types":["condition"],"url":"https://sah.borca.ai/concepts/co_76ee047ac6a9a97691fc0e6a73223033"},{"public_id":"co_c6ad32282f9b8c202f0e379a6d1cad49","name":"placebo response rate","description":"The proportion of patients in the placebo group who responded in the reviewed antidepressant trials.","types":["outcome"],"url":"https://sah.borca.ai/concepts/co_c6ad32282f9b8c202f0e379a6d1cad49"}],"related_claims":[],"url":"https://sah.borca.ai/claims/cl_136c2c8548021f5b64c05ca1c3f5c924"}